|Articles|June 15, 2004
Nidek's hyperopia algorithm tops FDA criteria
Fremont, CA-The FDA has given the go-ahead to an expansion of Nidek Inc.'s hyperopia study using new software for its U.S. EC-5000 platform.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Offline smartphone AI accurately detects DR, glaucoma, and AMD in real-world study
2
Dry Eye Awareness Month: building a strong optometry-ophthalmology co-management model
3
Thyroid eye disease specialists react to the FDA approval of veligrotug-vvze
4
From detection to decision-making: Navigating disease progression and treatment in geographic atrophy
5




















